Pathway specific gene expression profiling reveals oxidative stress genes potentially regulated by transcription co-activator LEDGF/p75 in prostate cancer cells

Prostate

Volumn 72, Issue 6, 2012, Pages 597-611

  Basu, Anamika ^a   Drame, Awa ^a   Muñoz, Ruben ^a   Gijsbers, Rik ^b   Debyser, Zeger ^b   De Leon, Marino ^a   Casiano, Carlos A ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

cytoglobin; gene profiling; LEDGF p75; oxidative stress; peroxiredoxin; prostate cancer

Indexed keywords

ALBUMIN; CYTOGLOBIN; EXTRACELLULAR SUPEROXIDE DISMUTASE; LENS EPITHELIUM DERIVED GROWTH FACTOR; ONCOPROTEIN; PEROXIREDOXIN 6; PROTEIN LENS EPITHELIUM DERIVED GROWTH FACTOR P75; THYROID PEROXIDASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL DEATH; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GLOBINS; HUMANS; MALE; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PROSTATE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84858753823     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21463     Document Type: Article

References (55)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60 (5): 277-300.
2. Chornokur G, Dalton K, Borysova ME, Kumar NB,. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate 2011; 71 (9): 985-997.
3. So A, Hadaschik B, Sowery R, Gleave M,. The role of stress proteins in prostate cancer. Curr Genomics 2007; 8 (4): 252-261. (Pubitemid 47240702)
4. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK,. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008; 68 (6): 1777-1785. (Pubitemid 351416563)
5. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK,. Oxidative stress in prostate cancer. Cancer Lett 2009; 282 (2): 125-136.
6. Basu A, Banerjee H, Rojas H, Martinez SR, Roy S, Jia Z, Lilly MB, De Leõn M, Casiano CA,. Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4. Prostate 2011; 71 (7): 755-765.
7. Singh DP, Ohguro N, Kikuchi T, Sueno T, Reddy VN, Yuge K, Chylack LT Jr, Shinohara T,. Lens epithelium-derived growth factor: Effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts. Biochem Biophys Res Commun 2000; 267 (1): 373-381. (Pubitemid 30072559)
8. Shinohara T, Singh DP, Fatma N,. LEDGF, a survival factor, activates stress-related genes. Prog Retin Eye Res 2002; 21 (3): 341-358. (Pubitemid 34607433)
9. Sharma P, Singh DP, Fatma N, Chylack LT Jr, Shinohara T,. Activation of LEDGF gene by thermal-and oxidative-stresses. Biochem Biophys Res Commun 2000; 276 (3): 1320-1324.
10. Ochs RL, Muro Y, Si Y, Ge H, Chan EK, Tan EM,. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 2000; 105 (6Pt1): 1211-1220. (Pubitemid 30418802)
11. Ge H, Si Y, Roeder RG,. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J 1998; 17 (22): 6723-6729. (Pubitemid 28521805)
12. Sutherland HG, Newton K, Brownstein DG, Holmes MC, Kress C, Semple CA, Bickmore WA,. Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations. Mol Cell Biol 2006; 26 (19): 7201-7210. (Pubitemid 44477696)
13. Ganapathy V, Casiano CA,. Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): What exactly are the autoantibodies trying to tell us? Arthritis Rheum 2004; 50 (3): 684-688. (Pubitemid 38326165)
14. Leoh LS, Mediavilla-Varela M, Basu A, Casiano CA,. Autoantibodies to LEDGFp75/DFS70: Natural autoantibodies or sensors of an augmented state of cellular oxidative stress? In:, Conrad K, Chan EKL, Fritzler MJ, Humbel RL, von Landenberg P, Shoenfeld Y, editors. From Pathogenesis to Therapy of Autoimmune Diseases. Lengerich: PABST Science Publishers; 2009. pp. 135-156.
15. Wu X, Daniels T, Molinaro C, Lilly MB, Casiano CA,. Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: Implications for autoimmunity in atopic disorders. Cell Death Differ 2002; 9 (9): 915-925. (Pubitemid 35023607)
16. Raz-Prag D, Zeng Y, Sieving PA, Bush RA,. Photoreceptor protection by adeno-associated virus-mediated LEDGF expression in the RCS rat model of retinal degeneration: Probing the mechanism. Invest Ophthalmol Vis Sci 2009; 50 (8): 3897-3906.
17. Sugiura K, Muro Y, Nishizawa Y, Okamoto M, Shinohara T, Tomita Y, Usukura J,. LEDGF/DFS70, a major autoantigen of atopic dermatitis, is a component of keratohyalin granules. J Invest Dermatol 2007; 127 (1): 75-80. (Pubitemid 46005663)
18. Takeichi T, Sugiura K, Muro Y, Matsumoto K, Ogawa Y, Futamura K, Kaminuma O, Hashimoto N, Shimoyama Y, Saito H, Tomita Y,. Overexpression of LEDGF/DFS70 induces IL-6 via p38 activation in HaCaT cells, similar to that seen in the psoriatic condition. J Invest Dermatol 2010; 130 (12): 2760-2767.
19. Van Maele B, Busschots K, Vandekerckhove L, Christ F, Debyser Z,. Cellular co-factors of HIV-1 integration. Trends Biochem Sci 2006; 31 (2): 98-105. (Pubitemid 43221842)
20. Engelman A, Cherepanov P,. The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS Pathog 2008; 4 (3): e1000046.
21. Llano M, Morrison J, Poeschla EM,. Virological and cellular roles of the transcriptional coactivator LEDGF/p75. Curr Top Microbiol Immunol 2009; 339: 125-146.
22. Daniels T, Zhang J, Gutierrez I, Elliot ML, Yamada B, Heeb MJ, Sheets SM, Wu X, Casiano CA,. Antinuclear autoantibodies in prostate cancer: Immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate 2005; 62 (1): 14-26. (Pubitemid 39614289)
23. Daugaard M, Kirkegaard-Søensen T, Ostenfeld MS, Aaboe M, Høyer-Hansen M, Orntoft TF, Rohde M, Jäättelä M,. Lens epithelium-derived growth factor is an Hsp70-2 regulated guardian of lysosomal stability in human cancer. Cancer Res 2007; 67 (6): 2559-25567.
24. Rammer P, Groth-Pedersen L, Kirkegaard T, Daugaard M, Rytter A, Szyniarowski P, Høyer-Hansen M, Povlsen LK, Nylandsted J, Larsen JE, Jäättelä M,. BAMLET activates a lysosomal cell death program in cancer cells. Mol Cancer Ther 2010; 9 (1): 24-32.
25. Mediavilla-Varela M, Pacheco FJ, Almaguel F, Perez J, Sahakian E, Daniels TR, Leoh LS, Padilla A, Wall NR, Lilly MB, De Leon M, Casiano CA,. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75. Mol Cancer 2009; 8: 68.
26. Huang TS, Myklebust LM, Kjarland E, Gjertsen BT, Pendino F, Bruserud Ø, Døskeland SO, Lillehaug JR,. LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro. Mol Cancer 2007; 6: 31.
27. Shin JH, Piao CS, Lim CM, Lee JK,. LEDGF binding to stress response element increases alphaB-crystallin expression in astrocytes with oxidative stress. Neurosci Lett 2008; 435 (2): 131-136.
28. Singh DP, Fatma N, Kimura A, Chylack LT Jr, Shinohara T,. LEDGF binds to heat shock and stress-related element to activate the expression of stress-related genes. Biochem Biophys Res Commun 2001; 283 (4): 943-955. (Pubitemid 32924672)
29. Singh DP, Kubo E, Takamura Y, Shinohara T, Kumar A, Chylack LT Jr, Fatma N,. DNA binding domains and nuclear localization signal of LEDGF: Contribution of two helix-turn-helix (HTH)-like domains and a stretch of 58 amino acids of the N-terminal to the trans-activation potential of LEDGF. J Mol Biol 2006; 355 (3): 379-394. (Pubitemid 41786967)
30. Brown-Bryan TA, Leoh LS, Ganapathy V, Pacheco FJ, Mediavilla-Varela M, Filippova M, Linkhart TA, Gijsbers R, Debyser Z, Casiano CA,. Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75. Mol Cancer Res 2008; 6 (8): 1293-1307.
31. Takamura Y, Fatma N, Kubo E, Singh DP,. Regulation of heavy subunit chain of gamma-glutamylcysteine synthetase by tumor necrosis factor-alpha in lens epithelial cells: Role of LEDGF/p75. Am J Physiol Cell Physiol 2006; 290 (2): C554-C566.
32. Cohen B, Addadi Y, Sapoznik S, Meir G, Kalchenko V, Harmelin A, Ben-Dor S, Neeman M,. Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75. Neoplasia 2009; 11 (9): 921-933.
33. Fatma N, Singh DP, Shinohara T,. Chylack LT Jr. Transcriptional regulation of the antioxidant protein 2 gene, a thiol-specific antioxidant, by lens epithelium-derived growth factor to protect cells from oxidative stress. J Biol Chem 2001; 276 (52): 48899-48907.
34. Fatma N, Kubo E, Chylack LT Jr, Shinohara T, Akagi Y, Singh DP,. LEDGF regulation of alcohol and aldehyde dehydrogenases in lens epithelial cells: Stimulation of retinoic acid production and protection from ethanol toxicity. Am J Physiol Cell Physiol 2004; 287 (2): C508-C516. (Pubitemid 38960789)
35. Kubo E, Fatma N, Sharma P, Shinohara T, Chylack LT Jr, Akagi Y, Singh DP,. Transactivation of involucrin, a marker of differentiation in keratinocytes, by lens epithelium-derived growth factor (LEDGF). J Mol Biol 2002; 320 (5): 1053-1063. (Pubitemid 34808823)
36. Maertens GN, Cherepanov P, Engelman A,. Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin. J Cell Sci 2006; 119 (12): 2563-2571. (Pubitemid 44070437)
37. Bartholomeeusen K, De Rijck J, Busschots K, Desender L, Gijsbers R, Emiliani S, Benarous R, Debyser Z, Christ F,. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75. J Mol Biol 2007; 372 (2): 407-421. (Pubitemid 47267963)
38. Yokoyama A, Cleary ML,. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 2008; 14 (1): 36-46. (Pubitemid 351885493)
39. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, Debyser Z, Engelborghs Y,. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 2003; 278 (35): 33528-33539. (Pubitemid 37055807)
40. Llano M, Saenz DT, Meehan A, Wongthida P, Peretz M, Walker WH, Teo W, Poeschla EM,. An essential role for LEDGF/p75 in HIV integration. Science 2006; 314 (5798): 461-464. (Pubitemid 44628966)
41. Patterson SG, Wei S, Chen X, Sallman DA, Gilvary DL, Zhong B, Pow-Sang J, Yeatman T, Djeu JY,. Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells. Oncogene 2006; 25 (45): 6113-6122. (Pubitemid 44562409)
42. Shivapurkar N, Stastny V, Okumura N, Girard L, Xie Y, Prinsen C, Thunnissen FB, Wistuba II, Czerniak B, Frenkel E, Roth JA, Liloglou T, Xinarianos G, Field JK, Minna JD, Gazdar AF,. Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene. Cancer Res 2008; 68 (18): 7448-7456.
43. Shaw RJ, Omar MM, Rokadiya S, Kogera FA, Lowe D, Hall GL, Woolgar JA, Homer J, Liloglou T, Field JK, Risk JM,. Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer. Br J Cancer 2009; 101 (1): 139-144.
44. Emara M, Turner AR, Allalunis-Turner J,. Hypoxic regulation of cytoglobin and neuroglobin expression in human normal and tumor tissues. Cancer Cell Int 2010; 10: 33.
45. Fordel E, Thijs L, Martinet W, Lenjou M, Laufs T, Van Bockstaele D, Moens L, Dewilde S,. Neuroglobin and cytoglobin overexpression protects human SH-SY5Y neuroblastoma cells against oxidative stress-induced cell death. Neurosci Lett 2006; 410 (2): 146-151. (Pubitemid 44709414)
46. Ciuffi A, Llano M, Poeschla E, Hoffmann C, Leipzig J, Shinn P, Ecker JR, Bushman F,. A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 2005; 11 (12): 1287-1289. (Pubitemid 41752906)
47. Shun MC, Raghavendra NK, Vandegraaff N, Daigle JE, Hughes S, Kellam P, Cherepanov P, Engelman A,. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev 2007; 21 (14): 1767-1778. (Pubitemid 47076476)
48. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E,. The antioxidant properties of serum albumin. FEBS Lett 2008; 582 (13): 1783-1787.
49. Chojkier M,. Inhibition of albumin synthesis in chronic diseases: Molecular mechanisms. J Clin Gastroenterol 2005; 39 (4): S143-S146. (Pubitemid 40397028)
50. Venkateswarlu K,. Interaction protein for cytohesin exchange factors 1 (IPCEF1) binds cytohesin 2 and modifies its activity. J Biol Chem 2003; 278 (44): 43460-43469. (Pubitemid 37345969)
51. White DT, McShea KM, Attar MA, Santy LC,. GRASP and IPCEF promote ARF-to-Rac signaling and cell migration by coordinating the association of ARNO/cytohesin 2 with Dock180. Mol Biol Cell 2010; 21 (4): 562-571.
52. Laatikainen LE, Castellone MD, Hebrant A, Hoste C, Cantisani MC, Laurila JP, Salvatore G, Salerno P, Basolo F, Näsman J, Dumont JE, Santoro M, Laukkanen MO,. Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer. Endocr Relat Cancer 2010; 17 (3): 785-796.
53. Teoh ML, Fitzgerald MP, Oberley LW, Domann FE,. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion. Cancer Res 2009; 69 (15): 6355-6363.
54. Smyth PP,. Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors 2003; 19 (3-4): 121-130. (Pubitemid 38175115)
55. De Rijck J, Bartholomeeusen K, Ceulemans H, Debyser Z, Gijsbers R,. High-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region. Nucleic Acids Res 2010; 38 (18): 6135-6147.